The Guangdong Provincial Center for Disease Control and Prevention and Guangdong Medicine Exchange jointly released the 2022 Guangdong Province Non-Immunization Program Vaccine Use Catalog of Supplementary Products (Seventh Batch). The updated list includes a wide range of non-immunization vaccines, providing more options for disease prevention and control.
Vaccine List
The non-immunization vaccines involved in the updated list cover various diseases, including influenza, rabies, hepatitis A, hepatitis B, varicella, Haemophilus influenzae type b, pneumococcal, rotavirus, enterovirus 71, meningitis, measles, pertussis, Japanese encephalitis, 2/4/9 HPV, tetanus, mumps, cholera, polio, and herpes zoster. This comprehensive list aims to address the diverse vaccine needs of the population.
Affected Companies
The release of the new catalog affects several multinational and domestic companies. Multinational companies such as Pfizer, Merck Sharp & Dohme, GlaxoSmithKline, and Sanofi are included, alongside domestic companies like Zhifei Bio, Changchun Institute of Biological Products, Kexing Bio, and Hualan Bio. The involvement of these companies ensures a robust supply chain and a variety of vaccine choices for the market.
Price Disclosure
All the prices of the new entries in the Guangdong Province Non-Immunization Program Vaccine Use Catalog have been disclosed. For more detailed information, please refer to the attached document.-Fineline Info & Tech
